Product Information
Name:IACS-13909
Brand:Biosynth
Description:IACS-13909 is a drug that binds to EGFR and inhibits the kinase activity of EGFR. It is being developed as an anti-cancer drug for the treatment of cancer, with a particular focus on cancers that are resistant to ibrutinib. IACS-13909 has shown potent anticancer activity in preclinical studies, with no adverse effects on healthy cells. IACS-13909 has been used in clinical trials for the treatment of cancer, with promising results.
Notice:Our products are intended for lab use only. For any other use, please contact us.
Chemical properties
Molecular weight:377.3 g/mol
Formula:C17H18Cl2N6
Purity:Min. 95%
Technical inquiry about: IACS-13909
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.